Johnson & Johnson MedTech’s Shockwave Medical has launched its Javelin Peripheral IVL Catheter in the US for peripheral artery disease (PAD). This new intravascular lithotripsy (IVL) platform is ...

Shockwave Medical, Inc. SWAV recently announced the full U.S. commercial availability of the Shockwave L6 Peripheral Intravascular Lithotripsy (IVL) Catheter. This follows the receipt of the FDA ...

Last month, Shockwave introduced the Javelin Peripheral IVL Catheter in the US market, targeting peripheral artery disease. "Shockwave begins study of IVL catheter for coronary artery lesions" was ...

This week, a number of companies, big and small, shared updates on their cardiovascular technology innovations at EuroPCR ...

Now available in the U.S., the Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter safely modifies and crosses occlusive or extremely narrowed calcific peripheral artery disease ...

Shockwave Medical announced the FDA clearance and U.S. launch of its peripheral intravascular lithotripsy (IVL) catheter. It is designed to treat calcified femoropopliteal and below-the-knee PAD ...

They emphasized the successful launch and impressive performance of their new L6 Peripheral IVL Catheter and the continued strong performance of the M5+. Management also expressed optimism ...

announced the full U.S. launch of the Shockwave E 8 Peripheral IVL Catheter, following clearance by the U.S. Food and Drug Administration (FDA). The Shockwave E 8 catheter is designed to optimize ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...